Evaluating the effectiveness of vaccines for flu and COVID-19 against acute illnesses in Texas.
RFA-IP-22-004, Component A _ Credible Effectiveness Measures of Seasonal Influenza, COVID-19 and Other Respiratory Virus Vaccines against Ambulatory Care for Acute Illness in Texas (and Component D).
This study is looking at how well the flu and COVID-19 vaccines help keep people in Central Texas from getting sick enough to need a doctor's visit, so we can better understand their effectiveness over time.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor Research Institute NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10910859 on NIH RePORTER |
What this research studies
This research investigates how well seasonal influenza and COVID-19 vaccines protect against acute illnesses that require outpatient care. By analyzing real-world data from patients in Central Texas, the study aims to provide accurate estimates of vaccine effectiveness over time. The research will focus on lab-confirmed cases of influenza and COVID-19, assessing how well the vaccines perform in preventing these infections. This information is crucial for public health efforts and for informing vaccination strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in Central Texas who are eligible for seasonal flu and COVID-19 vaccinations.
Not a fit: Patients who are not eligible for these vaccines or who do not reside in the study area may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies that better protect patients from respiratory illnesses.
How similar studies have performed: Previous research has shown success in evaluating vaccine effectiveness, making this approach both relevant and necessary.
Where this research is happening
Dallas, United States
- Baylor Research Institute — Dallas, United States (Active)
Researchers
- Principal investigator: Gaglani, Manjusha — Baylor Research Institute
- Study coordinator: Gaglani, Manjusha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.